US Stock MarketDetailed Quotes
KAPA Kairos Pharma
- 1.480
- +0.010+0.69%
Close Oct 18 16:00 ET
- 1.580
- +0.100+6.75%
Post 20:02 ET
19.01MMarket Cap-8222P/E (TTM)
1.530High1.330Low26.67KVolume1.490Open1.470Pre Close39.10KTurnover1.72%Turnover RatioLossP/E (Static)12.84MShares4.00052wk High-21.45P/B2.29MFloat Cap1.22052wk Low--Dividend TTM1.55MShs Float4.000Historical High--Div YieldTTM13.60%Amplitude1.220Historical Low1.465Avg Price1Lot Size
Kairos Pharma Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 4.72%222K | 127.78%287K | 200.18%1.71M | 505.00%1.09M | 131.45%287K | 76.67%212K | -14.29%126K | -70.61%571K | 180K | 124K |
| Selling and administrative expenses | -12.50%119K | 2.50%82K | 354.32%1.47M | 1,032.61%1.04M | 154.76%214K | 83.78%136K | 8.11%80K | -80.51%324K | --92K | --84K |
| -General and administrative expense | -12.50%119K | 2.50%82K | 354.32%1.47M | 1,032.61%1.04M | 154.76%214K | 83.78%136K | 8.11%80K | -80.51%324K | --92K | --84K |
| Research and development costs | 75.00%63K | 2,650.00%165K | -5.75%82K | -85.42%7K | --33K | 500.00%36K | -81.82%6K | -52.46%87K | --48K | --0 |
| Depreciation amortization depletion | 0.00%40K | 0.00%40K | 0.00%160K | 0.00%40K | 0.00%40K | 0.00%40K | 0.00%40K | 63.27%160K | --40K | --40K |
| -Depreciation and amortization | 0.00%40K | 0.00%40K | 0.00%160K | 0.00%40K | 0.00%40K | 0.00%40K | 0.00%40K | 63.27%160K | --40K | --40K |
| Operating profit | -4.72%-222K | -127.78%-287K | -200.18%-1.71M | -505.00%-1.09M | -131.45%-287K | -76.67%-212K | 14.29%-126K | 70.61%-571K | -180K | -124K |
| Net non-operating interest income expense | -29.17%-31K | -80.00%-36K | 79.54%-98K | -81.25%-29K | 77.27%-25K | 90.94%-24K | 77.27%-20K | -137.13%-479K | -16K | -110K |
| Non-operating interest expense | 29.17%31K | 80.00%36K | -78.65%98K | 81.25%29K | -77.27%25K | -90.94%24K | -70.59%20K | 179.88%459K | --16K | --110K |
| Total other finance cost | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -47.37%20K | --0 | ---- |
| Other net income (expense) | ||||||||||
| Income before tax | -7.20%-253K | -121.23%-323K | -72.57%-1.81M | -470.41%-1.12M | -33.33%-312K | 38.70%-236K | 37.87%-146K | 51.05%-1.05M | -196K | -234K |
| Income tax | ||||||||||
| Net income | -7.20%-253K | -121.23%-323K | -72.57%-1.81M | -470.41%-1.12M | -33.33%-312K | 38.70%-236K | 37.87%-146K | 51.05%-1.05M | -196K | -234K |
| Net income continuous Operations | -7.20%-253K | -121.23%-323K | -72.57%-1.81M | -470.41%-1.12M | -33.33%-312K | 38.70%-236K | 37.87%-146K | 51.05%-1.05M | ---196K | ---234K |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -7.20%-253K | -121.23%-323K | -72.57%-1.81M | -470.41%-1.12M | -33.33%-312K | 38.70%-236K | 37.87%-146K | 51.05%-1.05M | -196K | -234K |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -7.20%-253K | -121.23%-323K | -72.57%-1.81M | -470.41%-1.12M | -33.33%-312K | 38.70%-236K | 37.87%-146K | 51.05%-1.05M | -196K | -234K |
| Basic earnings per share | 0.00%-0.02 | -200.00%-0.03 | -70.00%-0.17 | -400.11%-0.11 | -40.36%-0.03 | 41.74%-0.02 | 52.27%-0.01 | 0.00%-0.1 | -0.022 | -0.0214 |
| Diluted earnings per share | 0.00%-0.02 | -200.00%-0.03 | -70.00%-0.17 | -400.11%-0.11 | -40.36%-0.03 | 41.74%-0.02 | 52.27%-0.01 | 0.00%-0.1 | -0.022 | -0.0214 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
